arrow
M

Melanie M. Ashton

medicine
H指数:15
被引数:906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocol

一项关于联合使用曲美他嗪治疗双相抑郁患者的国际、双盲、随机、安慰剂对照临床试验方案(TIDE试验方案)。

2026-04-030
OAAI
The efficacy of adjunctive Garcinia mangostana Linn. (mangosteen) pericarp extract for bipolar depression: 24-week randomised controlled trial

Garcinia mangostana Linn.(山竹)果皮提取物辅助治疗双相抑郁的疗效:一项为期24周的随机对照试验

2025-07-010
OAAI
REPURPOSING CANDESARTAN, THE ANTIHYPERTENSIVE DRUG, FOR TREATMENT OF BIPOLAR DISORDER

将抗高血压药物坎地沙坦用于治疗双相障碍

2025-02-120
OA
Patterns of pharmacotherapy for bipolar disorder: A GBC survey

双相情感障碍的药物治疗模式: GBC调查

2023-07-1823
OAAI
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
2023-06-295
OAAI
Coping with COVID-19: Exploring coping strategies, distress, and post-traumatic growth during the COVID-19 pandemic in Australia

应对新型冠状病毒肺炎: 探索澳大利亚新型冠状病毒肺炎大流行期间的应对策略,痛苦和创伤后成长

2022-10-2010
OAAI
Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les medicaments a base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une meta-revue des meta-analyses d'essais randomises controles
2021-02-1820
OAAI
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials
2020-10-2225
PREAI
Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial

重度抑郁症的人格障碍和功能: 一项随机对照试验中的嵌套研究

2020-02-016
OAAI